Monitoring and antibacterial treatment for postoperative bacterial overgrowth in Crohn's disease

被引:16
|
作者
Funayama, Y
Sasaki, I
Naito, H
Fukushima, K
Shibata, C
Masuko, T
Takahashi, K
Ogawa, H
Sato, S
Ueno, T
Noguchi, M
Hiwatashi, N
Matsuno, S
机构
[1] Tohoku Univ, Sch Med, Dept Surg 1, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Sch Med, Dept Internal Med 3, Aoba Ku, Sendai, Miyagi 9808574, Japan
关键词
Crohn's disease; bacterial overgrowth syndrome; hydrogen breath test; antibiotics;
D O I
10.1007/BF02236706
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PURPOSE: Bacterial overgrowth sometimes complicates the clinical course of Crohn's disease and may lead to inappropriate treatment. To clarify the effect of antibiotic therapy, we monitored the hydrogen concentration in expiratory breath after fasting. METHODS: We evaluated 18 patients (15 males; median age, 32.7; range, 22.3-60 years) for postoperative bacterial overgrowth symptoms and for intestinal dilation by plain abdominal x-ray. Five patients had ileitis and 13 patients had ileocolitis. Various intestinal resections were performed in all, and strictureplasties were done at the same time in 13 patients. The median postoperative period was 10.2 (range, 1.2-102) months. Nine patients, who had symptoms such as bloating, nausea, vomiting, or pain, were classified as the symptomatic group, whereas nine other patients, who had no symptoms, were classified as the symptom-free group. Sixteen patients who bad undergone intestinal resections for noninflammatory bowel disease served as the control group. After overnight fasting, hydrogen concentration in end-expiratory breath was measured with gas chromatography. At the same time clinical examinations of white blood cell count, hemoglobin, total protein, serum albumin, iron, sialic acid, and C-reactive protein in the peripheral blood were performed. To assess the effect of antibacterial treatment, changes in symptoms were assessed in eight patients who received antibacterial treatment. Hydrogen concentration was measured repeatedly before and after treatment in six patients. RESULTS: The symptomatic group had an expiratory hydrogen concentration level significantly higher (median, 40; range, 20-139 ppm) than the control group (median, 3; range, 1-6 ppm) and the symptom-free group (median, 4; range, 1-10 ppm). After the antibiotic treatment the symptoms were improved in all of the patients, and the hydrogen concentration level was significantly reduced (median, 4.5; range, 2-13 ppm). CONCLUSIONS: Antibacterial treatment was useful in the postoperative patients whose assessments were complicated by bacterial overgrowth. Using a hydrogen breath test, bacterial overgrowth was effectively monitored and managed, effecting a change in clinical symptoms.
引用
收藏
页码:1072 / 1077
页数:6
相关论文
共 50 条
  • [31] Postoperative Therapy for Crohn's Disease
    Blum, Eric
    Katz, Jeffry A.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (03) : 463 - 472
  • [32] A Review of Postoperative Crohn's Disease
    Collins, Clyde A.
    Potru, Rachana
    Green, Jesse
    PRACTICAL GASTROENTEROLOGY, 2011, 35 (05) : 20 - 30
  • [33] Management of postoperative Crohn's disease
    Ng, Siew C.
    Kamm, Michael A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (04): : 1029 - 1035
  • [34] Management of postoperative Crohn's disease
    Yang, Zhiping
    Wu, Qiong
    Wu, Kaichun
    Fan, Daiming
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 811 - 818
  • [35] Postoperative Crohn's disease management
    Barnes, Edward L.
    CURRENT OPINION IN GASTROENTEROLOGY, 2020, 36 (04) : 277 - 283
  • [36] Ustekinumab Is A Promising Option For The Treatment Of Postoperative Recurrence Of Crohn's Disease
    Macaluso, F. S.
    Grova, M.
    Mocciaro, F.
    Di Mitri, R.
    Privitera, A. C.
    Distefano, M. E.
    Vitello, A.
    Camilleri, S.
    Ferracane, C.
    Pluchino, D.
    Belluardo, N.
    Giangreco, E.
    Fries, W.
    Viola, A.
    Cappello, M.
    Amato, L.
    Bertolami, C.
    Ventimiglia, M.
    Renna, S.
    Casa, A.
    De Vivo, S.
    Orlando, A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 528 - 528
  • [37] Successful Treatment of Postoperative Fistula with Infliximab in a Patient with Crohn's Disease
    Jeong, Seong Yeon
    Moon, Jeong Seop
    Park, Kyu Joo
    Kim, You Sun
    INTESTINAL RESEARCH, 2014, 12 (01) : 74 - 77
  • [38] USTEKINUMAB IS A PROMISING OPTION FOR THE TREATMENT OF POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE
    Macaluso, F. S.
    Grova, M.
    Mocciaro, F.
    Di Mitri, R.
    Privitera, A. C.
    Distefano, M. E.
    Vitello, A.
    Camilleri, S.
    Ferracane, C.
    Pluchino, D.
    Belluardo, N.
    Giangreco, E.
    Fries, W.
    Viola, A.
    Cappello, M.
    D'Amato, L.
    Bertolami, C.
    Ventimiglia, M.
    Renna, S.
    Casa, A.
    De Vivo, S.
    Orlando, A.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S159 - S160
  • [39] Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease
    Macaluso, Fabio Salvatore
    Grova, Mauro
    Mocciaro, Filippo
    Di Mitri, Roberto
    Privitera, Antonino Carlo
    Distefano, Maria Emanuela
    Vitello, Alessandro
    Camilleri, Salvatore
    Ferracane, Concetta
    Pluchino, Dario
    Belluardo, Nunzio
    Giangreco, Emiliano
    Fries, Walter
    Viola, Anna
    Cappello, Maria
    D'Amato, Livia
    Bertolami, Carmelo
    Ventimiglia, Marco
    Renna, Sara
    Casa, Angelo
    D'Antonio, Elvira
    De Vivo, Simona
    Orlando, Ambrogio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 (09) : 1503 - 1509
  • [40] Bacterial imbalance in Crohn's disease
    Ursula Hofer
    Nature Reviews Microbiology, 2014, 12 : 313 - 313